跳至主要内容
临床试验/NCT01130298
NCT01130298已完成1 期

An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt Barrier

AbbVie0 个研究点目标入组 24 人开始时间: 2010年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
24
主要终点
Average Plasma Concentration observed (Cav)

研究概览

简要总结

Single-center, single dose, open-label study in healthy male and female volunteers to further characterize the transfer potential of Testosterone Gel 1.62% formulation.

详细描述

Single-center, single dose, open-label study in 12 healthy male and 12 healthy female volunteers to further characterize the transfer potential of Testosterone Gel 1.62% formulation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

干预措施: Testosterone Gel 1.62% (Drug)

结局指标

主要结局

Average Plasma Concentration observed (Cav)

时间窗: Up to 5 days

Average Plasma Concentration observed (Cav) of total testosterone

Maximum Plasma Concentration observed (Cmax)

时间窗: Up to 5 days

Maximum plasma concentration observed (Cmax) of total testosterone

Area Under the Plasma Concentration-time Curve (AUC)

时间窗: Up to 5 days

Area under the plasma concentration-time curve (AUC) of total testosterone

次要结局

未报告次要终点

研究者

发起方
AbbVie
申办方类型
Industry
责任方
Sponsor

相似试验